Bennani-Baiti Barbara, Toegel Stefan, Viernstein Helmut, Urban Ernst, Noe Christian R, Bennani-Baiti Idriss M
Department for Medicinal Chemistry, Institute of Pharmaceutical Chemistry, University of Vienna, Althanstrasse 14, 1090 Vienna, Austria; Department of Biomedical Imaging and Image-guided Therapy, Vienna General Hospital (AKH), Medical University of Vienna, Waehringer-Guertel 18-20, 1090 Vienna, Austria.
Karl Chiari Lab for Orthopaedic Biology, Department of Orthopaedics, Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria.
PLoS One. 2015 Sep 25;10(9):e0139101. doi: 10.1371/journal.pone.0139101. eCollection 2015.
Endothelial cells are often present at inflammation sites. This is the case of endothelial cells of the blood-brain barrier (BBB) of patients afflicted with neurodegenerative disorders such as Alzheimer's, Parkinson's, or multiple sclerosis, as well as in cases of bacterial meningitis, trauma, or tumor-associated ischemia. Inflammation is a known modulator of gene expression through the activation of transcription factors, mostly NF-κB. RLIP76 (a.k.a. RALBP1), an ATP-dependent transporter of electrophile-glutathione conjugates, modulates BBB permeability through the regulation of tight junction function, cell adhesion, and exocytosis. Genes and pathways regulated by RLIP76 are transcriptional targets of tumor necrosis factor alpha (TNF-α) pro-inflammatory molecule, suggesting that RLIP76 may also be an inflammation target. To assess the effects of TNF-α on RLIP76, we faced the problem of choosing reference genes impervious to TNF-α. Since such genes were not known in human BBB endothelial cells, we subjected these to TNF-α, and measured by quantitative RT-PCR the expression of housekeeping genes commonly used as reference genes. We find most to be modulated, and analysis of several inflammation datasets as well as a metaanalysis of more than 5000 human tissue samples encompassing more than 300 cell types and diseases show that no single housekeeping gene may be used as a reference gene. Using three different algorithms, however, we uncovered a reference geneset impervious to TNF-α, and show for the first time that RLIP76 expression is induced by TNF-α and follows the induction kinetics of inflammation markers, suggesting that inflammation can influence RLIP76 expression at the BBB. We also show that MRP1 (a.k.a. ABCC1), another electrophile-glutathione transporter, is not modulated in the same cells and conditions, indicating that RLIP76 regulation by TNF-α is not a general property of glutathione transporters. The reference geneset uncovered herein should aid in future gene expression studies in inflammatory conditions of the BBB.
内皮细胞常出现在炎症部位。患有神经退行性疾病(如阿尔茨海默病、帕金森病或多发性硬化症)的患者血脑屏障(BBB)的内皮细胞就是这种情况,在细菌性脑膜炎、创伤或肿瘤相关缺血的情况下也是如此。炎症是通过转录因子(主要是NF-κB)的激活来调节基因表达的已知调节因子。RLIP76(也称为RALBP1)是一种亲电体-谷胱甘肽偶联物的ATP依赖性转运蛋白,通过调节紧密连接功能、细胞粘附和胞吐作用来调节血脑屏障通透性。RLIP76调控的基因和信号通路是肿瘤坏死因子α(TNF-α)促炎分子的转录靶点,这表明RLIP76也可能是炎症靶点。为了评估TNF-α对RLIP76的影响,我们面临选择不受TNF-α影响的参考基因的问题。由于在人血脑屏障内皮细胞中不存在这样已知的基因,我们将这些细胞暴露于TNF-α,并通过定量RT-PCR测量常用作参考基因的管家基因的表达。我们发现大多数管家基因受到调节,对几个炎症数据集的分析以及对涵盖300多种细胞类型和疾病的5000多个人类组织样本的荟萃分析表明,没有单一管家基因可作为参考基因。然而,使用三种不同算法,我们发现了一组不受TNF-α影响的参考基因,并首次表明RLIP76表达受TNF-α诱导,并遵循炎症标志物的诱导动力学,这表明炎症可影响血脑屏障处的RLIP76表达。我们还表明,另一种亲电体-谷胱甘肽转运蛋白MRP1(也称为ABCC1)在相同细胞和条件下不受调节,这表明TNF-α对RLIP76的调节不是谷胱甘肽转运蛋白的普遍特性。本文发现的参考基因集应有助于未来在血脑屏障炎症条件下的基因表达研究。